Glynis Bennett, lead nurse infection prevention and control, Queen Elizabeth Hospital Kings Lynn (QEHKL) NHS Foundation Trust, talks about the roll out of octenisan body wash and how it has helped drive down cases of MRSA.
Improved infection prevention and control has helped drive a marked reduction in the number of cases of Methicillin-resistant Staphylococcus aureus (MRSA) in the blood (bacteraemia) in England.
According to Public Health England, for example, the number of cases of MRSA bacteraemia declined by 86% between April-June 2007 and July-September 2016. Despite these promising findings, MRSA is a long way from being eradicated: between July-September 2016 the rates of MRSA bacteraemia were two cases per 100,000 of the population in men and 0.9 per 100,000 among women.1
The Queen Elizabeth Hospital Kings Lynn NHS Foundation Trust (QEHKL) aims at zero cases of MRSA bacteraemia. However, the QEHKL cares for a relatively large number of elderly patients and, in 2015-16, the Trust documented evidence of clusters of MRSA colonisations in which MRSA spread from patient-to-patient, such as on dementia wards.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
